help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emanuelli, G.
Right arrow Articles by Gubetta, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emanuelli, G.
Right arrow Articles by Gubetta, L.

American Journal of Pathology, Vol 134, 315-326, Copyright © 1989 by American Society for Investigative Pathology

REGULAR ARTICLES

Experimental acute pancreatitis induced by platelet activating factor in rabbits

G Emanuelli, G Montrucchio, E Gaia, L Dughera, G Corvetti and L Gubetta
Clinica Medica Generale, Universita' di Torino, Ospedale S. Luigi Gonzaga, Orbassano, Italy.

This study indicates that a single injection of platelet activating factor (PAF, 50-500 ng) into the superior pancreaticoduodenal artery of rabbits induces dose-dependent morphologic alterations of pancreatic tissue and increases serum amylase levels, both consistent with the development of an acute pancreatitis. The main histologic findings observed by light microscopy 24-72 hours after the injection of PAF were edema, polymorphonuclear neutrophil infiltration, cell vacuolization, and acinar cell necrosis. Fat cell necrosis was present in 30% of animals. By electron microscopy an increase of the number of zymogen granules in the apical region of acinar cells was observed 3 hours after PAF challenge. At 24-72 hours, many acinar cells showed vacuoles containing myelinlike figures, zymogen granules, and cellular debris. Pancreatic lesions developed in the area supplied by the artery injected with PAF and they were completely antagonized by the pretreatment of rabbits with CV 3988, a specific antagonist of PAF. In addition, the significant protective effect of atropine suggests a potential role for cholinergic mechanisms in the pancreatic alterations induced by PAF.


This article has been cited by other articles:


Home page
 GutHome page
C D Johnson, A N Kingsnorth, C W Imrie, M J McMahon, J P Neoptolemos, C McKay, S K C Toh, P Skaife, P C Leeder, P Wilson, et al.
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute
Gut, January 1, 2001; 48(1): 62 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
B. D. Flickinger and M. S. Olson
Localization of the Platelet-Activating Factor Receptor to Rat Pancreatic Microvascular Endothelial Cells
Am. J. Pathol., May 1, 1999; 154(5): 1353 - 1358.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Society for Investigative Pathology.